These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8820266)

  • 41. A novel leukocyte chemotactic and activating cytokine, interleukin-8 (IL-8).
    Mukaida N; Harada A; Matsushima K
    Cancer Treat Res; 1995; 80():261-86. PubMed ID: 8821581
    [No Abstract]   [Full Text] [Related]  

  • 42. Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence that both cytokines act through the same receptor.
    Kotowicz K; Callard RE; Friedrich K; Matthews DJ; Klein N
    Int Immunol; 1996 Dec; 8(12):1915-25. PubMed ID: 8982776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-13: characterization and biologic properties.
    McKenzie AN; Zurawski G
    Cancer Treat Res; 1995; 80():367-78. PubMed ID: 8821586
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of interleukin 13 in classical Hodgkin lymphoma.
    Skinnider BF; Kapp U; Mak TW
    Leuk Lymphoma; 2002 Jun; 43(6):1203-10. PubMed ID: 12152987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway.
    Murata T; Husain SR; Mohri H; Puri RK
    Int Immunol; 1998 Aug; 10(8):1103-10. PubMed ID: 9723696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2.
    Wood N; Whitters MJ; Jacobson BA; Witek J; Sypek JP; Kasaian M; Eppihimer MJ; Unger M; Tanaka T; Goldman SJ; Collins M; Donaldson DD; Grusby MJ
    J Exp Med; 2003 Mar; 197(6):703-9. PubMed ID: 12642602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-4 and its receptor: essential mediators of the allergic response.
    Ryan JJ
    J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):1-5. PubMed ID: 9003204
    [No Abstract]   [Full Text] [Related]  

  • 48. Inhibition of human IgE synthesis in vitro and in SCID-hu mice by an interleukin-4 receptor antagonist.
    Carballido JM; Aversa G; Schols D; Punnonen J; de Vries JE
    Int Arch Allergy Immunol; 1995; 107(1-3):304-7. PubMed ID: 7613155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-13 and IL-4 share signal transduction elements as well as receptor components in TF-1 cells.
    Lefort S; Vita N; Reeb R; Caput D; Ferrara P
    FEBS Lett; 1995 Jun; 366(2-3):122-6. PubMed ID: 7789528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
    Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Interleukin-6 (IL-6) receptor].
    Sakamoto K; Ogawa M; Sakamoto K
    Nihon Rinsho; 1997 Apr; 55 Suppl 2():538-41. PubMed ID: 9172585
    [No Abstract]   [Full Text] [Related]  

  • 52. Cytokine pleiotropy and redundancy--gp130 cytokines in human implantation.
    Sánchez-Cuenca J; Martín JC; Pellicer A; Simón C
    Immunol Today; 1999 Feb; 20(2):57-9. PubMed ID: 10098321
    [No Abstract]   [Full Text] [Related]  

  • 53. IL-4/IL-13 signaling beyond JAK/STAT.
    Jiang H; Harris MB; Rothman P
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1063-70. PubMed ID: 10856136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit.
    Lai SY; Molden J; Liu KD; Puck JM; White MD; Goldsmith MA
    EMBO J; 1996 Sep; 15(17):4506-14. PubMed ID: 8887542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC. A comparison between IL-4 and IL-13.
    Deleuran B; Iversen L; Deleuran M; Yssel H; Kragballe K; Stengaard-Pedersen K; Thestrup-Pedersen K
    Cytokine; 1995 May; 7(4):319-24. PubMed ID: 8589261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor.
    Fourcin M; Chevalier S; Lebrun JJ; Kelly P; Pouplard A; Wijdenes J; Gascan H
    Eur J Immunol; 1994 Jan; 24(1):277-80. PubMed ID: 8020567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13.
    Serve H; Oelmann E; Herweg A; Oberberg D; Serve S; Reufi B; Mücke C; Minty A; Thiel E; Berdel WE
    Cancer Res; 1996 Aug; 56(15):3583-8. PubMed ID: 8758930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor.
    Ryan JJ; McReynolds LJ; Keegan A; Wang LH; Garfein E; Rothman P; Nelms K; Paul WE
    Immunity; 1996 Feb; 4(2):123-32. PubMed ID: 8624803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Solution structure of human IL-13 and implication for receptor binding.
    Moy FJ; Diblasio E; Wilhelm J; Powers R
    J Mol Biol; 2001 Jun; 310(1):219-30. PubMed ID: 11419948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
    Doucet C; Giron-Michel J; Canonica GW; Azzarone B
    Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.